ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
120.767,19
-1,73%
S&P 500
5.346,99
-0,11%
US Dollar vs BRL
5,3461
0,00%
Bitcoin
69.387,61
0,08%
Brent Oil
79,395
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. CorMedix Inc (CRMD)

  7. CorMedix Inc (CRMD) Notícias

CRMD

CorMedix (CRMD)

CorMedix Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CRMD
DataHoraFonteTítuloCódigoCompanhia
06/06/202409:30GlobeNewswire Inc.CorMedix Inc. Announces CMS Grants Pass-Through Status to DefencathNASDAQ:CRMDCorMedix Inc
23/05/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:CRMDCorMedix Inc
13/05/202417:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
09/05/202418:06Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CRMDCorMedix Inc
09/05/202409:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRMDCorMedix Inc
09/05/202408:40Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRMDCorMedix Inc
19/04/202409:30GlobeNewswire Inc.CorMedix Inc. Announces CMS Grants TDAPA to DefenCathNASDAQ:CRMDCorMedix Inc
15/04/202409:30GlobeNewswire Inc.CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)NASDAQ:CRMDCorMedix Inc
12/03/202408:30GlobeNewswire Inc.CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
18/01/202418:53Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:CRMDCorMedix Inc
14/12/202318:05Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:CRMDCorMedix Inc
14/11/202318:05GlobeNewswire Inc.CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
11/10/202309:30GlobeNewswire Inc.CorMedix Inc. Announces Abstract Presentation at Upcoming IDWeek ConferenceNASDAQ:CRMDCorMedix Inc
13/09/202318:26Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:CRMDCorMedix Inc
13/09/202318:25Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CRMDCorMedix Inc
13/09/202318:20Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:CRMDCorMedix Inc
08/09/202309:30GlobeNewswire Inc.CorMedix Inc. Announces Publication of Phase 3 LOCK IT-100 Study Data in the Clinical Journal of The American Society of NephrologyNASDAQ:CRMDCorMedix Inc
30/08/202309:00GlobeNewswire Inc.CorMedix Inc. Announces Issuance of U.S. Patent Covering Lead Product DefencathNASDAQ:CRMDCorMedix Inc
08/08/202308:30GlobeNewswire Inc.CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
30/06/202317:38Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:CRMDCorMedix Inc
28/06/202323:57GlobeNewswire Inc.CorMedix Inc. Announces Pricing of $40 Million Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:CRMDCorMedix Inc
28/06/202318:14Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:CRMDCorMedix Inc
28/06/202317:07GlobeNewswire Inc.CorMedix Inc. Announces Proposed Public Offering of Common Stock and Pre-Funded WarrantsNASDAQ:CRMDCorMedix Inc
21/06/202309:43Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CRMDCorMedix Inc
21/06/202309:30GlobeNewswire Inc.CorMedix Inc. Announces FDA Acceptance of Resubmission of New Drug Application for DefenCathNASDAQ:CRMDCorMedix Inc
15/06/202309:30GlobeNewswire Inc.Cormedix Inc. Announces Strategic Initiative With Boston Medical Center to Reduce Health Disparities in Patients at Risk for Bloodstream InfectionsNASDAQ:CRMDCorMedix Inc
19/05/202317:03Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CRMDCorMedix Inc
18/05/202319:26Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/a)NASDAQ:CRMDCorMedix Inc
16/05/202308:00GlobeNewswire Inc.CorMedix Inc. Announces Resubmission of New Drug Application for DefenCathNASDAQ:CRMDCorMedix Inc
15/05/202317:05GlobeNewswire Inc.CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business UpdateNASDAQ:CRMDCorMedix Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CRMD

Seu Histórico Recente

COIN
KP4RUSD
Keep4r
NASDAQ
PFEL
AXS 2X PFE Bull Daily ETF
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados